No differences between men and women in adverse drug reactions related to psychotropic drugs: a survey from France, Italy and Spain

A large number of studies have suggested that being a woman represents a potential risk factor for the development of adverse drug reactions (ADRs). The aim of this study is to further explore the differences between men and women with regard to reported ADRs, particularly those associated with psyc...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:Fundamental & clinical pharmacology 2014-06, Vol.28 (3), p.342-348
Hauptverfasser: D'Incau, Paola, Lapeyre-Mestre, Maryse, Carvajal, Alfonso, Donati, Monia, Salado, Inés, Rodriguez, Lauriane, Sáinz, María, Escudero, Antonio, Conforti, Anita
Format: Artikel
Sprache:eng
Schlagworte:
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
container_end_page 348
container_issue 3
container_start_page 342
container_title Fundamental & clinical pharmacology
container_volume 28
creator D'Incau, Paola
Lapeyre-Mestre, Maryse
Carvajal, Alfonso
Donati, Monia
Salado, Inés
Rodriguez, Lauriane
Sáinz, María
Escudero, Antonio
Conforti, Anita
description A large number of studies have suggested that being a woman represents a potential risk factor for the development of adverse drug reactions (ADRs). The aim of this study is to further explore the differences between men and women with regard to reported ADRs, particularly those associated with psychotropic drugs. We used spontaneous reports of suspected ADRs collected by Midi‐Pyrénées (France), Veneto (Italy) and Castilla y León (Spain) Regional Pharmacovigilance Centres (January 2007–December 2009). All the reports including a psychotropic medication were selected in a first step; age distribution, seriousness and type of ADRs were compared between men and women. Reports of nonpsychotropic drugs were similarly identified and treated. The absolute number of reports and the proportion, considering population, were higher in women than in men. This was observed for all reports, but was particularly higher for psychotropic drugs (592 vs. 375; P 
doi_str_mv 10.1111/fcp.12032
format Article
fullrecord <record><control><sourceid>proquest_pubme</sourceid><recordid>TN_cdi_proquest_miscellaneous_1517399797</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>1517399797</sourcerecordid><originalsourceid>FETCH-LOGICAL-i3542-7605751c2f8f50c54fbf120718dab91a275a44f957f56d1439fefebcde627b123</originalsourceid><addsrcrecordid>eNpFkUtv1DAUhS0EotPCgj-AvEFiQVo_4jhhByNmaDUqIIpgZznONRiSONhJp1nzx_E8KJYsH8vfuVfXB6FnlJzTtC6sGc4pI5w9QAuaS5aVjBQP0YLIQma8KukJOo3xJyFUElo8RieMF1TmIl-gP9ceN85aCNAbiLiGcQvQ4y5t3Td463fKpUtzCyECbsL0HQfQZnS-j0m1eoQGjx4PcTY__Bj84Mwei6-xxnEKtzBjG3yHV0GnJq_w5ajbeV_-86Bd_wQ9srqN8PR4nqEvq3c3y_fZ5sP6cvlmkzkucpbJgggpqGG2tIIYkdvapqklLRtdV1QzKXSe20pIK4qG5ryyYKE2DRRM1pTxM_TyUHcI_vcEcVSdiwbaVvfgp6iooJJXlaxkQp8f0anuoFFDcJ0Os_r3cQl4cQR0NLq1u8lc_M-VvKJlteMuDtzWtTDfv1OidsmplJzaJ6dWy497kRzZweHiCHf3Dh1-qUJyKdTX67XaXNGrt-tP39QN_wu03JqC</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>1517399797</pqid></control><display><type>article</type><title>No differences between men and women in adverse drug reactions related to psychotropic drugs: a survey from France, Italy and Spain</title><source>MEDLINE</source><source>Wiley Online Library Journals Frontfile Complete</source><creator>D'Incau, Paola ; Lapeyre-Mestre, Maryse ; Carvajal, Alfonso ; Donati, Monia ; Salado, Inés ; Rodriguez, Lauriane ; Sáinz, María ; Escudero, Antonio ; Conforti, Anita</creator><creatorcontrib>D'Incau, Paola ; Lapeyre-Mestre, Maryse ; Carvajal, Alfonso ; Donati, Monia ; Salado, Inés ; Rodriguez, Lauriane ; Sáinz, María ; Escudero, Antonio ; Conforti, Anita</creatorcontrib><description>A large number of studies have suggested that being a woman represents a potential risk factor for the development of adverse drug reactions (ADRs). The aim of this study is to further explore the differences between men and women with regard to reported ADRs, particularly those associated with psychotropic drugs. We used spontaneous reports of suspected ADRs collected by Midi‐Pyrénées (France), Veneto (Italy) and Castilla y León (Spain) Regional Pharmacovigilance Centres (January 2007–December 2009). All the reports including a psychotropic medication were selected in a first step; age distribution, seriousness and type of ADRs were compared between men and women. Reports of nonpsychotropic drugs were similarly identified and treated. The absolute number of reports and the proportion, considering population, were higher in women than in men. This was observed for all reports, but was particularly higher for psychotropic drugs (592 vs. 375; P &lt; 0.001) than for nonpsychotropics drugs (5193 vs. 4035; P &lt; 0.001). Antidepressants were the most reported (women, 303; men, 141; P &lt; 0.001); the reporting rates (number of reports divided by exposed patients in the same period, estimated through sales data) for these drugs, however, were not significantly different between women (0.87 cases per 10 000 treated persons per year) and men (0.81 cases per 10 000 treated persons per year). Although there was a higher number of reports of ADRs in women, ADR reporting rates might be similar as highlighted by the case of antidepressants. Antidepressant ADRs in fact were similarly reported in men and in women. Gender differences are sometimes subtle and difficult to explore. International networks, as the one established for this study, do contribute to better analyse problems associated with medications.</description><identifier>ISSN: 0767-3981</identifier><identifier>EISSN: 1472-8206</identifier><identifier>DOI: 10.1111/fcp.12032</identifier><identifier>PMID: 23617454</identifier><identifier>CODEN: FCPHEZ</identifier><language>eng</language><publisher>Oxford: Blackwell Publishing Ltd</publisher><subject>Adverse Drug Reaction Reporting Systems ; Biological and medical sciences ; Chi-Square Distribution ; Data Interpretation, Statistical ; Drug-Related Side Effects and Adverse Reactions - epidemiology ; Drug-Related Side Effects and Adverse Reactions - etiology ; France - epidemiology ; gender ; Humans ; Italy - epidemiology ; Male ; Medical sciences ; Pharmacology. Drug treatments ; pharmacovigilance ; Psychotropic Drugs - adverse effects ; psychotropics ; reporting ; Sex Characteristics ; Spain - epidemiology</subject><ispartof>Fundamental &amp; clinical pharmacology, 2014-06, Vol.28 (3), p.342-348</ispartof><rights>2013 The Authors Fundamental and Clinical Pharmacology © 2013 Société Française de Pharmacologie et de Thérapeutique</rights><rights>2015 INIST-CNRS</rights><rights>2013 The Authors Fundamental and Clinical Pharmacology © 2013 Société Française de Pharmacologie et de Thérapeutique.</rights><lds50>peer_reviewed</lds50><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktopdf>$$Uhttps://onlinelibrary.wiley.com/doi/pdf/10.1111%2Ffcp.12032$$EPDF$$P50$$Gwiley$$H</linktopdf><linktohtml>$$Uhttps://onlinelibrary.wiley.com/doi/full/10.1111%2Ffcp.12032$$EHTML$$P50$$Gwiley$$H</linktohtml><link.rule.ids>314,776,780,1411,27903,27904,45552,45553</link.rule.ids><backlink>$$Uhttp://pascal-francis.inist.fr/vibad/index.php?action=getRecordDetail&amp;idt=28391894$$DView record in Pascal Francis$$Hfree_for_read</backlink><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/23617454$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>D'Incau, Paola</creatorcontrib><creatorcontrib>Lapeyre-Mestre, Maryse</creatorcontrib><creatorcontrib>Carvajal, Alfonso</creatorcontrib><creatorcontrib>Donati, Monia</creatorcontrib><creatorcontrib>Salado, Inés</creatorcontrib><creatorcontrib>Rodriguez, Lauriane</creatorcontrib><creatorcontrib>Sáinz, María</creatorcontrib><creatorcontrib>Escudero, Antonio</creatorcontrib><creatorcontrib>Conforti, Anita</creatorcontrib><title>No differences between men and women in adverse drug reactions related to psychotropic drugs: a survey from France, Italy and Spain</title><title>Fundamental &amp; clinical pharmacology</title><addtitle>Fundam Clin Pharmacol</addtitle><description>A large number of studies have suggested that being a woman represents a potential risk factor for the development of adverse drug reactions (ADRs). The aim of this study is to further explore the differences between men and women with regard to reported ADRs, particularly those associated with psychotropic drugs. We used spontaneous reports of suspected ADRs collected by Midi‐Pyrénées (France), Veneto (Italy) and Castilla y León (Spain) Regional Pharmacovigilance Centres (January 2007–December 2009). All the reports including a psychotropic medication were selected in a first step; age distribution, seriousness and type of ADRs were compared between men and women. Reports of nonpsychotropic drugs were similarly identified and treated. The absolute number of reports and the proportion, considering population, were higher in women than in men. This was observed for all reports, but was particularly higher for psychotropic drugs (592 vs. 375; P &lt; 0.001) than for nonpsychotropics drugs (5193 vs. 4035; P &lt; 0.001). Antidepressants were the most reported (women, 303; men, 141; P &lt; 0.001); the reporting rates (number of reports divided by exposed patients in the same period, estimated through sales data) for these drugs, however, were not significantly different between women (0.87 cases per 10 000 treated persons per year) and men (0.81 cases per 10 000 treated persons per year). Although there was a higher number of reports of ADRs in women, ADR reporting rates might be similar as highlighted by the case of antidepressants. Antidepressant ADRs in fact were similarly reported in men and in women. Gender differences are sometimes subtle and difficult to explore. International networks, as the one established for this study, do contribute to better analyse problems associated with medications.</description><subject>Adverse Drug Reaction Reporting Systems</subject><subject>Biological and medical sciences</subject><subject>Chi-Square Distribution</subject><subject>Data Interpretation, Statistical</subject><subject>Drug-Related Side Effects and Adverse Reactions - epidemiology</subject><subject>Drug-Related Side Effects and Adverse Reactions - etiology</subject><subject>France - epidemiology</subject><subject>gender</subject><subject>Humans</subject><subject>Italy - epidemiology</subject><subject>Male</subject><subject>Medical sciences</subject><subject>Pharmacology. Drug treatments</subject><subject>pharmacovigilance</subject><subject>Psychotropic Drugs - adverse effects</subject><subject>psychotropics</subject><subject>reporting</subject><subject>Sex Characteristics</subject><subject>Spain - epidemiology</subject><issn>0767-3981</issn><issn>1472-8206</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2014</creationdate><recordtype>article</recordtype><sourceid>EIF</sourceid><recordid>eNpFkUtv1DAUhS0EotPCgj-AvEFiQVo_4jhhByNmaDUqIIpgZznONRiSONhJp1nzx_E8KJYsH8vfuVfXB6FnlJzTtC6sGc4pI5w9QAuaS5aVjBQP0YLIQma8KukJOo3xJyFUElo8RieMF1TmIl-gP9ceN85aCNAbiLiGcQvQ4y5t3Td463fKpUtzCyECbsL0HQfQZnS-j0m1eoQGjx4PcTY__Bj84Mwei6-xxnEKtzBjG3yHV0GnJq_w5ajbeV_-86Bd_wQ9srqN8PR4nqEvq3c3y_fZ5sP6cvlmkzkucpbJgggpqGG2tIIYkdvapqklLRtdV1QzKXSe20pIK4qG5ryyYKE2DRRM1pTxM_TyUHcI_vcEcVSdiwbaVvfgp6iooJJXlaxkQp8f0anuoFFDcJ0Os_r3cQl4cQR0NLq1u8lc_M-VvKJlteMuDtzWtTDfv1OidsmplJzaJ6dWy497kRzZweHiCHf3Dh1-qUJyKdTX67XaXNGrt-tP39QN_wu03JqC</recordid><startdate>201406</startdate><enddate>201406</enddate><creator>D'Incau, Paola</creator><creator>Lapeyre-Mestre, Maryse</creator><creator>Carvajal, Alfonso</creator><creator>Donati, Monia</creator><creator>Salado, Inés</creator><creator>Rodriguez, Lauriane</creator><creator>Sáinz, María</creator><creator>Escudero, Antonio</creator><creator>Conforti, Anita</creator><general>Blackwell Publishing Ltd</general><general>Blackwell</general><scope>BSCLL</scope><scope>IQODW</scope><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>7X8</scope></search><sort><creationdate>201406</creationdate><title>No differences between men and women in adverse drug reactions related to psychotropic drugs: a survey from France, Italy and Spain</title><author>D'Incau, Paola ; Lapeyre-Mestre, Maryse ; Carvajal, Alfonso ; Donati, Monia ; Salado, Inés ; Rodriguez, Lauriane ; Sáinz, María ; Escudero, Antonio ; Conforti, Anita</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-i3542-7605751c2f8f50c54fbf120718dab91a275a44f957f56d1439fefebcde627b123</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2014</creationdate><topic>Adverse Drug Reaction Reporting Systems</topic><topic>Biological and medical sciences</topic><topic>Chi-Square Distribution</topic><topic>Data Interpretation, Statistical</topic><topic>Drug-Related Side Effects and Adverse Reactions - epidemiology</topic><topic>Drug-Related Side Effects and Adverse Reactions - etiology</topic><topic>France - epidemiology</topic><topic>gender</topic><topic>Humans</topic><topic>Italy - epidemiology</topic><topic>Male</topic><topic>Medical sciences</topic><topic>Pharmacology. Drug treatments</topic><topic>pharmacovigilance</topic><topic>Psychotropic Drugs - adverse effects</topic><topic>psychotropics</topic><topic>reporting</topic><topic>Sex Characteristics</topic><topic>Spain - epidemiology</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>D'Incau, Paola</creatorcontrib><creatorcontrib>Lapeyre-Mestre, Maryse</creatorcontrib><creatorcontrib>Carvajal, Alfonso</creatorcontrib><creatorcontrib>Donati, Monia</creatorcontrib><creatorcontrib>Salado, Inés</creatorcontrib><creatorcontrib>Rodriguez, Lauriane</creatorcontrib><creatorcontrib>Sáinz, María</creatorcontrib><creatorcontrib>Escudero, Antonio</creatorcontrib><creatorcontrib>Conforti, Anita</creatorcontrib><collection>Istex</collection><collection>Pascal-Francis</collection><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>MEDLINE - Academic</collection><jtitle>Fundamental &amp; clinical pharmacology</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>D'Incau, Paola</au><au>Lapeyre-Mestre, Maryse</au><au>Carvajal, Alfonso</au><au>Donati, Monia</au><au>Salado, Inés</au><au>Rodriguez, Lauriane</au><au>Sáinz, María</au><au>Escudero, Antonio</au><au>Conforti, Anita</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>No differences between men and women in adverse drug reactions related to psychotropic drugs: a survey from France, Italy and Spain</atitle><jtitle>Fundamental &amp; clinical pharmacology</jtitle><addtitle>Fundam Clin Pharmacol</addtitle><date>2014-06</date><risdate>2014</risdate><volume>28</volume><issue>3</issue><spage>342</spage><epage>348</epage><pages>342-348</pages><issn>0767-3981</issn><eissn>1472-8206</eissn><coden>FCPHEZ</coden><abstract>A large number of studies have suggested that being a woman represents a potential risk factor for the development of adverse drug reactions (ADRs). The aim of this study is to further explore the differences between men and women with regard to reported ADRs, particularly those associated with psychotropic drugs. We used spontaneous reports of suspected ADRs collected by Midi‐Pyrénées (France), Veneto (Italy) and Castilla y León (Spain) Regional Pharmacovigilance Centres (January 2007–December 2009). All the reports including a psychotropic medication were selected in a first step; age distribution, seriousness and type of ADRs were compared between men and women. Reports of nonpsychotropic drugs were similarly identified and treated. The absolute number of reports and the proportion, considering population, were higher in women than in men. This was observed for all reports, but was particularly higher for psychotropic drugs (592 vs. 375; P &lt; 0.001) than for nonpsychotropics drugs (5193 vs. 4035; P &lt; 0.001). Antidepressants were the most reported (women, 303; men, 141; P &lt; 0.001); the reporting rates (number of reports divided by exposed patients in the same period, estimated through sales data) for these drugs, however, were not significantly different between women (0.87 cases per 10 000 treated persons per year) and men (0.81 cases per 10 000 treated persons per year). Although there was a higher number of reports of ADRs in women, ADR reporting rates might be similar as highlighted by the case of antidepressants. Antidepressant ADRs in fact were similarly reported in men and in women. Gender differences are sometimes subtle and difficult to explore. International networks, as the one established for this study, do contribute to better analyse problems associated with medications.</abstract><cop>Oxford</cop><pub>Blackwell Publishing Ltd</pub><pmid>23617454</pmid><doi>10.1111/fcp.12032</doi><tpages>7</tpages><oa>free_for_read</oa></addata></record>
fulltext fulltext
identifier ISSN: 0767-3981
ispartof Fundamental & clinical pharmacology, 2014-06, Vol.28 (3), p.342-348
issn 0767-3981
1472-8206
language eng
recordid cdi_proquest_miscellaneous_1517399797
source MEDLINE; Wiley Online Library Journals Frontfile Complete
subjects Adverse Drug Reaction Reporting Systems
Biological and medical sciences
Chi-Square Distribution
Data Interpretation, Statistical
Drug-Related Side Effects and Adverse Reactions - epidemiology
Drug-Related Side Effects and Adverse Reactions - etiology
France - epidemiology
gender
Humans
Italy - epidemiology
Male
Medical sciences
Pharmacology. Drug treatments
pharmacovigilance
Psychotropic Drugs - adverse effects
psychotropics
reporting
Sex Characteristics
Spain - epidemiology
title No differences between men and women in adverse drug reactions related to psychotropic drugs: a survey from France, Italy and Spain
url https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-28T07%3A31%3A53IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_pubme&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=No%20differences%20between%20men%20and%20women%20in%20adverse%20drug%20reactions%20related%20to%20psychotropic%20drugs:%20a%20survey%20from%20France,%20Italy%20and%20Spain&rft.jtitle=Fundamental%20&%20clinical%20pharmacology&rft.au=D'Incau,%20Paola&rft.date=2014-06&rft.volume=28&rft.issue=3&rft.spage=342&rft.epage=348&rft.pages=342-348&rft.issn=0767-3981&rft.eissn=1472-8206&rft.coden=FCPHEZ&rft_id=info:doi/10.1111/fcp.12032&rft_dat=%3Cproquest_pubme%3E1517399797%3C/proquest_pubme%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=1517399797&rft_id=info:pmid/23617454&rfr_iscdi=true